PDE Screening and Profiling Services
- PDE Screening and Profiling Flyer
- PDE Cell Based Screening Flyer
- PDE Promotion
- PDE Products
- PDE Sample Report
Looking for more?
BPS has the largest selection of PDE assays available. Accelerate your drug discovery program with BPS's biochemical and cell based PDE Screening and Profiling Services from BPS Bioscience, Inc. Utilize BPS’s PDE screening and profiling services to accelerate your drug discovery programs. Trust us to provide you with high quality data with fast turnaround time. Our team of experts along with our broad services portfolio makes it easy to:
- Screen for inhibitors/targets using our panel of 20+ assays
- Select from IC50 determination and single point concentrations
- Receive data within days of compound submission
- Perform follow-up studies using the same proteins manufactured in-house
- Get questions answered or project guidance in a time-efficient manner
Contact BPS Bioscience today for more information about our PDE screening and profiling services.
Biochemical Assay Format:
Fill out the Compound Submission Form and include it with your compounds when shipping in addition to emailing it to the email address provided on the form.
When mailing compounds, follow these detailed shipping instructions.
Please note: In order to minimize the turnaround time for service orders, please fill out the Compound Submission Form as completely as possible. Failure to include a Compound Submission Form with accurate and complete information will result in delayed screens.
Phosphodiesterase, or PDE, is an enzyme which hydrolyzes phosphodiesterase bonds. PDEs regulate subcellular signal transduction through the degradation of cyclic nucleotides. Inhibition of PDEs has become an exciting area of clinical significance. Through inhibiting PDEs, cyclic nucleotides like cAMP and cGMP can remain active and act as second messengers. PDE inhibition can have widespread pharmacological effects depending upon the type of phosphodiesterase that is inhibited.
Through inhibiting phosphodiesterase 3, intracellular concentrations of cAMP rise. In combination with other intracellular messengers, cAMP stimulates cardiac muscles. Many PDE3 inhibitors have been developed to treat cardiac failures, cardiogenic shock, and hypertension. Since heart disease is the leading cause of death in the United States, PDE inhibition has become a major pharmacological target of interest.
There is a vast array of pharmacological applications for PDE inhibition. Inhibition of this enzyme has been used to treat a wide variety of disorders such as asthma, COPD, schizophrenia, and malaria. BPS Bioscience offers the largest selection of PDE assays commercially available. Additionally, BPS provides an expansive variety of PDE related products.
- Fluorescence Polarization
Not quite what you’re looking for? Our Custom Assay Development Services allow for flexibility to meet your specific research needs